CD80 and breast carcinoma: that NDV infected MCF-7 cells have beneficial effects on the antigen presentation capacity of breast cancer patient derived dendritic cells demonstrated by an upregulation of CD40, CD80, CD83, CD86 and MHC class II (HLA-DR).